We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
C-Max, Biomedica Nutraceuticals Pty Ltd, CON-986
Product name
C-Max
Sponsor name
Biomedica Nutraceuticals Pty Ltd
ARTG details
Batches
37466B
Consent start
Consent no.
CON-986
Duration
The consent is effective from 5 May 2022 until the stated batch/es are exhausted or 5 May 2024.
Standard
Therapeutic Goods Order No. 101 - Standard for Tablets, Capsules and Pills (TGO 101) Order 2019
Non-compliance with standard
The product does not comply because the estimated average content of Zinc is
141.0% of the label claim. As a result, this is outside the upper limit of the
TGO 101 Schedule 2 requirements for the content of a mineral in a listed product
of 90.0 - 125.0%.
Conditions imposed
The content of Zinc for the stated batch/es must be no less than 90% and no
more than 141.0% of the stated content on the label.
Import, Supply, &/or Export
Supply
Therapeutic product type
Listed complementary medicines